Last reviewed · How we verify
Simulant agent for Zhi Kang Capsule — Competitive Intelligence Brief
marketed
Small molecule
Live · refreshed every 30 min
Target snapshot
Simulant agent for Zhi Kang Capsule (Simulant agent for Zhi Kang Capsule) — Peking University People's Hospital.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| Simulant agent for Zhi Kang Capsule TARGET | Simulant agent for Zhi Kang Capsule | Peking University People's Hospital | marketed |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- Simulant agent for Zhi Kang Capsule CI watch — RSS
- Simulant agent for Zhi Kang Capsule CI watch — Atom
- Simulant agent for Zhi Kang Capsule CI watch — JSON
- Simulant agent for Zhi Kang Capsule alone — RSS
Cite this brief
Drug Landscape (2026). Simulant agent for Zhi Kang Capsule — Competitive Intelligence Brief. https://druglandscape.com/ci/simulant-agent-for-zhi-kang-capsule. Accessed 2026-05-17.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab